TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Duration of Therapy
KW - Humans
KW - Methadone/therapeutic use
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy
KW - United States/epidemiology
KW - Veterans
KW - Veterans Health
KW - buprenorphine
KW - medications for addiction treatment
KW - Methadone
KW - opioid use disorder
KW - simulation modeling
AU - J. H. Ching
AU - D. K. Owens
AU - J. A. Trafton
AU - J. D. Goldhaber-Fiebert
AU - J. A. Salomon
A1 - 
AD - Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, CA, USA.; Program Evaluation and Resource Center, Office of Mental Health and Suicide Prevention, VA Palo Alto Health Care System, Menlo Park, CA, USA.; Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, CA, USA.; VA Palo Alto Health Care System, Palo Alto, CA, USA.; Program Evaluation and Resource Center, Office of Mental Health and Suicide Prevention, VA Palo Alto Health Care System, Menlo Park, CA, USA.; Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, CA, USA.; Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, CA, USA.
BT - Addiction (Abingdon, England)
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 12
DO - 10.1111/add.15574
IS - 12
JF - Addiction (Abingdon, England)
LA - eng
M1 - Journal Article
PB - Society for the Study of Addiction. This article has been contributed to by US Government employees and their work is in the public domain in the USA
PY - 2021
SN - 1360-0443; 0965-2140; 0965-2140
SP - 3494
EP - 3503
EP - 
T1 - Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration
T2 - Addiction (Abingdon, England)
TI - Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 33999485
U3 - 10.1111/add.15574
VL - 116
VO - 1360-0443; 0965-2140; 0965-2140
Y1 - 2021
Y2 - Dec
ER -